ES2164901T3 - Derivados de alcaloides policiclicos como antagonistas de los receptores del nmda. - Google Patents

Derivados de alcaloides policiclicos como antagonistas de los receptores del nmda.

Info

Publication number
ES2164901T3
ES2164901T3 ES96922703T ES96922703T ES2164901T3 ES 2164901 T3 ES2164901 T3 ES 2164901T3 ES 96922703 T ES96922703 T ES 96922703T ES 96922703 T ES96922703 T ES 96922703T ES 2164901 T3 ES2164901 T3 ES 2164901T3
Authority
ES
Spain
Prior art keywords
alkyl
pct
antagonists
independently
nmda
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96922703T
Other languages
English (en)
Inventor
John Dimaio
Dilip M Dixit
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shire Canada Inc
Original Assignee
Shire BioChem Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire BioChem Inc filed Critical Shire BioChem Inc
Application granted granted Critical
Publication of ES2164901T3 publication Critical patent/ES2164901T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/44Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton bound to carbon atoms of the same ring or condensed ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D225/00Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/08Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D313/00Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/16Eight-membered rings
    • C07D313/20Eight-membered rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D337/00Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/16Eight-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

ALCALOIDES POLICICLICOS DE FORMULA (I) EN LOS QUE R SUB,1} ES H, ALQUILO C SUB,1-6}, O ARILO C SUB,6-12} OPCIONALMENTE SUSTITUIDO CON GRUPOS POLARES; R SUB,2} Y R SUB,3} SON INDEPENDIENTEMENTE H, OH, ALQUILO C SUB,1-6} O HALOGENO; O R SUB,2} Y R SUB,3} JUNTOS FORMAN UN ANILLO DE 5 A 6 MIEMBROS QUE INCORPORA OPCIONALMENTE UN HETEROATOMO; R SUB,4} ES H, ALQUILO C SUB,1-6}, OR SUB,6}, SR SUB,6} O N(R SUB,6}) SUB,2}, EN DONDE CADA R SUB,6} ES INDEPENDIENTEMENTE H, ALQUILO C SUB,1-3}; X ES O, S, SO, SO SUB,2}, N DE CADA R SUB,5} ES INDEPENDIENTEMENTE H, ALQUILO C SUB,1-6}, O ARALQUILO C SUB,7-13} OPCIONALMENTE INTERRUMPIDO CON UNO O MAS HETEROATOMOS; N ES UN ENTERO DE 0 A 2; M ES UN ENTERO DE 0 A 3; CON LA CONDICION DE QUE CUANDO X ES CH SUB,2} ENTONCES R SUB,1} NO ES CH SUB,3}, R SUB,2} Y R SUB,3} NO SON AMBOS H, R SUB,4} NO ES OH, M NO ES 3 Y N NO ES 0. PUEDEN ACTUAR COMO ANTAGONISTAS EN EL RECEPTOR IONOTROPICO NMDA (ACIDO N D) ASPARTICO).
ES96922703T 1995-07-14 1996-07-12 Derivados de alcaloides policiclicos como antagonistas de los receptores del nmda. Expired - Lifetime ES2164901T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9514448.1A GB9514448D0 (en) 1995-07-14 1995-07-14 Novel heterocyclic NMDA-receptor antagonists

Publications (1)

Publication Number Publication Date
ES2164901T3 true ES2164901T3 (es) 2002-03-01

Family

ID=10777682

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96922703T Expired - Lifetime ES2164901T3 (es) 1995-07-14 1996-07-12 Derivados de alcaloides policiclicos como antagonistas de los receptores del nmda.

Country Status (12)

Country Link
US (1) US5990104A (es)
EP (1) EP0840731B1 (es)
JP (1) JPH11509533A (es)
CN (1) CN1195344A (es)
AT (1) ATE206616T1 (es)
AU (1) AU696502B2 (es)
CA (1) CA2223644A1 (es)
DE (1) DE69615845T2 (es)
ES (1) ES2164901T3 (es)
GB (1) GB9514448D0 (es)
NO (1) NO980145D0 (es)
WO (1) WO1997003979A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001247762A1 (en) * 2000-03-28 2001-10-08 Delorenzo, Robert, J Inhibition of a novel calcium injury current that forms in neurons during injury prevents neuronal cell death
AUPR215700A0 (en) * 2000-12-19 2001-01-25 Fujisawa Pharmaceutical Co., Ltd. Carboxylic acid compound having cyclopropane ring
EP2425845A1 (en) * 2004-12-23 2012-03-07 Voyager Pharmaceutical Corporation Acetylcholinesterase Inhibitors and leuprolide acetate for the treatment of Alzheimer's disease
US20220117913A1 (en) * 2019-02-02 2022-04-21 Yangtze River Pharmaceutical Group Co., Ltd. Dezocine derivative and medical use thereof
CN112137996B (zh) * 2020-10-23 2023-08-25 湖南农业大学 一种预防钩吻中毒的药物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3836670A (en) * 1971-11-19 1974-09-17 American Home Prod Benzobicycloalkane amines for inducing analgesia
US4957909A (en) * 1989-05-04 1990-09-18 American Home Products Corporation Benzobicycloalkane derivatives as anticonvulsant neuroprotective agents

Also Published As

Publication number Publication date
AU696502B2 (en) 1998-09-10
DE69615845T2 (de) 2002-06-20
GB9514448D0 (en) 1995-09-13
EP0840731A1 (en) 1998-05-13
US5990104A (en) 1999-11-23
NO980145L (no) 1998-01-13
CA2223644A1 (en) 1997-02-06
EP0840731B1 (en) 2001-10-10
JPH11509533A (ja) 1999-08-24
ATE206616T1 (de) 2001-10-15
DE69615845D1 (de) 2001-11-15
WO1997003979A1 (en) 1997-02-06
AU6350296A (en) 1997-02-18
CN1195344A (zh) 1998-10-07
NO980145D0 (no) 1998-01-13

Similar Documents

Publication Publication Date Title
NO931151L (no) Fremgangsmaate for fremstilling av nitrogenholdige heterocykliske forbindelser med kondenserte ringer
RS52522B (en) 1-ALKYL-1-AZONIABICYCLE DERIVATIVES / 2.2.2. / OCTAN CARBAMATE AND THEIR USE AS AN ANTAGONIST OF MUSCAR RECEPTORS
FR2442845A1 (fr) Derives amines spiranniques, leur preparation et leur utilisation comme medicaments
HUP0202989A2 (hu) Új hidantoin-, tiohidantoin-, pirimidindion- és tioxopirimidinon-származékok, eljárás előállításukra és gyógyszerként való alkalmazásuk
ES2000935A6 (es) Un procedimiento para la preparacion de 3-imidazolin-metiltetrahidrocarbazolonas.
ES2164901T3 (es) Derivados de alcaloides policiclicos como antagonistas de los receptores del nmda.
ES2000936A6 (es) Un procedimiento para la preparacion de 3-imidazolin -metiltetrahidrocarbazolonas.
PT874841E (pt) Derivados da 1-benzenossulfonilpirrolidina como antagonistas do receptor da bradiquinina
IE811580L (en) Herbicidal compounds
GR1000156B (el) ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΝΕΩΝ ΠΑΡΑΓΩΓΩΝ ΤΡΙΚΥΚΛΙΚΩΝ ΑΜΙΝΩΝ ΤΗΣ ΤΕΤΡΑΥΔΡΟ-5,6,7,8ΝΑΦΘΟ[2,3b] ΔΙΥΔΡΟ-2,3 ΦΟΥΡΑΝΗΣ & ΤΗΣ ΤΕΤΡΑΥΔΡΟ-6,7,8,9 5Η-ΒΕΝΖΟΚΥΚΛΟΕΠΤΑ[2,3Β] ΔΙΥΔΡΟ-2,3 ΦΟΥΡΑΝΗΣ.
ES8609302A1 (es) Un procedimiento para la preparacion de 4-amino-2-fenilqui- nolinas
FI974609A (fi) Uusia heterosyklisiä yhdisteitä kivun hoitoon ja niiden käyttö
AP9801410A0 (en) Indoline derivatives useful as 5-HT-2C receptor antagonists.
TR200001080T2 (tr) 2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri
MX9603199A (es) Antagonistas de receptores a endotelina.
MY110751A (en) Positive inotropic and lusitropic pyrroloquinolinone derivatives
MX9800281A (es) Compuestos heterociclicos nuevos para el tratamiento de dolores y uso de los mismos.
PT92494A (pt) Processo para a preparacao de novos derivados do indol
ES8704459A1 (es) Procedimiento para la obtencion de acemetacina.
ES8207530A1 (es) Un procedimiento para la produccion de nuevos derivados del tetrahidroimidazo (2,1-b)tiazol
ES8707509A1 (es) Procedimiento de preparacion de nuevos condensados de 1-2-4 triazinas.
ES8506014A1 (es) Procedimiento para la preparacion de derivados de acridanona.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 840731

Country of ref document: ES